APOLLO HOSPITALS ENTER. L (APOLLOHOSP) financials
APOLLO HOSPITALS ENTER. L (APOLLOHOSP) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, i…
- Market Cap: ₹1,13,446Cr.
- Current Price: ₹7,890
- Stock P/E: 71.8
- ROE: 15.0%
- ROCE: 17.0%
- Book Value: ₹693
- Dividend Yield: 0.25%
- 52W High / Low: ₹9,327/6,680
In Jun 2026, APOLLO HOSPITALS ENTER. L (APOLLOHOSP) reported sales ₹2,656 Cr and net profit ₹385 Cr.
Annual TTM: sales ₹9,814 Cr, net profit ₹1,571 Cr.
Shareholding: Promoters 28.02% (Sep 2026), FIIs 43.19% (Sep 2026), DIIs 22.07% (Sep 2026), Government 0.23% (Sep 2026), Public 6.49% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,135 | 2,055 | 2,075 | 2,168 | 2,356 | 2,364 | 2,438 | 2,656 |
| Expenses | 1,595 | 1,543 | 1,554 | 1,622 | 1,763 | 1,770 | 1,843 | 2,000 |
| Operating Profit | 540 | 512 | 521 | 546 | 593 | 594 | 596 | 656 |
| OPM % | 25% | 25% | 25% | 25% | 25% | 25% | 24% | 25% |
| Other Income | 121 | 108 | 92 | 32 | 141 | 97 | 90 | 47 |
| Interest | 65 | 62 | 63 | 59 | 58 | 62 | 63 | 68 |
| Depreciation | 108 | 108 | 130 | 123 | 122 | 127 | 128 | 134 |
| Profit before tax | 488 | 449 | 420 | 397 | 554 | 502 | 494 | 501 |
| Tax % | 24% | 24% | 21% | 23% | 24% | 24% | 23% | 23% |
| Net Profit | 370 | 342 | 333 | 307 | 420 | 384 | 382 | 385 |
| EPS in Rs | 25.71 | 23.76 | 23.19 | 21.34 | 29.20 | 26.67 | 26.60 | 26.79 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 9,794 | 4,654 | 6,098 | 6,525 | 7,274 | 8,202 | 9,326 | 9,814 |
| Expenses | 8,377 | 3,938 | 4,677 | 4,831 | 5,476 | 6,152 | 6,993 | 7,376 |
| Operating Profit | 1,418 | 715 | 1,421 | 1,694 | 1,798 | 2,050 | 2,334 | 2,438 |
| OPM % | 14% | 15% | 23% | 26% | 25% | 25% | 25% | 25% |
| Other Income | 173 | 137 | 131 | 139 | 180 | 342 | 355 | 375 |
| Interest | 426 | 340 | 244 | 239 | 250 | 254 | 242 | 251 |
| Depreciation | 482 | 421 | 363 | 367 | 399 | 449 | 500 | 512 |
| Profit before tax | 682 | 91 | 945 | 1,228 | 1,329 | 1,688 | 1,946 | 2,050 |
| Tax % | 31% | -15% | 30% | 12% | 24% | 23% | 23% | — |
| Net Profit | 470 | 105 | 665 | 1,085 | 1,010 | 1,296 | 1,493 | 1,571 |
| EPS in Rs | 33.80 | 7.30 | 46.26 | 75.45 | 70.28 | 90.16 | 103.81 | 109.26 |
| Dividend Payout % | 18% | 41% | 25% | 20% | 23% | 14% | 19% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 70 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 3,814 | 3,919 | 5,130 | 6,039 | 6,853 | 7,639 | 8,662 | 9,891 |
| Borrowings | 3,238 | 3,160 | 3,050 | 2,752 | 2,520 | 3,222 | 3,090 | 3,190 |
| Other Liabilities | 1,307 | 2,996 | 1,478 | 1,545 | 1,335 | 1,472 | 1,548 | 1,762 |
| Total Liabilities | 8,428 | 10,144 | 9,729 | 10,408 | 10,780 | 12,405 | 13,372 | 14,914 |
| Fixed Assets | 3,970 | 6,056 | 5,038 | 5,121 | 5,078 | 6,032 | 6,348 | 6,916 |
| CWIP | 819 | 227 | 219 | 24 | 96 | 200 | 306 | 320 |
| Investments | 1,085 | 1,076 | 2,091 | 2,059 | 2,217 | 2,621 | 3,911 | 4,893 |
| Other Assets | 2,554 | 2,786 | 2,381 | 3,204 | 3,389 | 3,553 | 2,807 | 2,786 |
| Total Assets | 8,428 | 10,144 | 9,729 | 10,408 | 10,780 | 12,405 | 13,372 | 14,914 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 907 | 1,096 | 916 | 1,201 | 1,224 | 1,191 | 1,742 | 2,059 |
| Cash from Investing Activity | -776 | -264 | -781 | -504 | -588 | -835 | -1,046 | -1,413 |
| Cash from Financing Activity | -160 | -771 | -176 | -577 | -779 | -297 | -739 | -537 |
| Net Cash Flow | -28 | 62 | -41 | 120 | -143 | 59 | -43 | 109 |
| Free Cash Flow | 324 | 660 | 722 | 682 | 831 | 572 | 897 | 1,019 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 104% | 95% | 127% | 91% | 91% | 85% | 103% | 108% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 29.33% | 29.34% | 29.34% | 28.02% | 28.02% | 28.02% | 28.02% | 28.02% |
| FIIs | 45.27% | 42.74% | 43.49% | 44.20% | 43.54% | 42.62% | 41.49% | 43.19% |
| DIIs | 19.97% | 22.29% | 21.34% | 21.12% | 21.50% | 22.76% | 23.72% | 22.07% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 5.21% | 5.41% | 5.61% | 6.43% | 6.71% | 6.39% | 6.53% | 6.49% |
| No. of Shareholders | 1,27,802 | 1,34,058 | 1,41,007 | 1,60,556 | 1,78,648 | 1,74,610 | 1,74,281 | 1,72,863 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 36 | 94 | 49 | 46 | 41 | 36 | 33 |
| Inventory Days | 47 | 50 | 63 | 28 | 19 | 22 | — | — |
| Days Payable | 45 | 51 | 254 | 124 | 124 | 138 | — | — |
| Cash Conversion Cycle | 42 | 35 | -96 | -46 | -59 | -76 | 36 | 33 |
| Working Capital Days | 3 | -0 | 12 | 72 | 73 | 64 | 2 | -6 |
| ROCE % | 11% | 13% | 4% | 13% | 16% | 15% | 16% | 17% |
Apollo Hospitals Enter. L
₹1,13,446Cr.
₹7,890
₹9,327/6,680
71.8
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,Primary Care & Diagnostic Clinics and several Retail Health models.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of APOLLO HOSPITALS ENTER. L (APOLLOHOSP)?
The reported market capitalisation for APOLLO HOSPITALS ENTER. L (APOLLOHOSP) is ₹1,13,446Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of APOLLOHOSP?
The current price shown for APOLLO HOSPITALS ENTER. L (APOLLOHOSP) on Fincrux is ₹7,890 with a 52-week high/low of ₹9,327/6,680.
What is the P/E ratio of APOLLO HOSPITALS ENTER. L (APOLLOHOSP)?
The stock P/E for APOLLO HOSPITALS ENTER. L (APOLLOHOSP) is 71.8 on Fincrux, with ROE at 15.0% and ROCE at 17.0%.
What were APOLLOHOSP latest quarterly results?
For Jun 2026, APOLLO HOSPITALS ENTER. L (APOLLOHOSP) reported sales ₹2,656 Cr and net profit ₹385 Cr (figures in ₹ crore unless noted).
What are APOLLOHOSP annual sales and net profit?
For TTM, APOLLO HOSPITALS ENTER. L (APOLLOHOSP) shows sales of ₹9,814 Cr and net profit of ₹1,571 Cr on the Fincrux profit & loss statement.
Who owns APOLLO HOSPITALS ENTER. L (APOLLOHOSP)?
Latest shareholding for APOLLO HOSPITALS ENTER. L (APOLLOHOSP) on Fincrux: Promoters 28.02% (Sep 2026), FIIs 43.19% (Sep 2026), DIIs 22.07% (Sep 2026), Government 0.23% (Sep 2026), Public 6.49% (Sep 2026).
Where can I find APOLLO HOSPITALS ENTER. L (APOLLOHOSP) financials?
APOLLO HOSPITALS ENTER. L (APOLLOHOSP) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show APOLLOHOSP balance sheet and cash flow?
Yes. The APOLLO HOSPITALS ENTER. L (APOLLOHOSP) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.